Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 EXCLUSIVE MANUFACTURING AND SUPPLY OF SYNTHETIC PSILOCYBIN FOR OUR DRUG PRODUCTS Tryp has secured an exclusive supply of our psilocybin-based active ingredients and drug products, with sufficient quantities of material to support clinical trials and ultimate commercialization—a rare capability among psychedelic drug development companies. 24 Curia (formerly AMRIԻ manufactures our Active Pharmaceutical Ingredient (APIԻ through a proprietary process. We’ve already completed engineering batches for our API, and expect to have more than 2 kg of cGMP material in 2021. Our Partners Alcami manufactures and develops analytical methods for our final drug products. Working at scale We are already scaled for full commercial quantities.